SanRetus Medica - Company finances
|
EUR
|
2022
From: 2022-12-29
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 7,393 | 20,354 | 36,090 |
| Profit before tax | 0 | -7,159 | -1,709 | 1,590 |
| Net profit | 0 | -7,159 | -1,709 | 1,685 |
| Equity | 0 | 1,515 | 10 | 2,244 |
| Liabilities | 0 | 0 | 0 | 0 |
| Non-current assets | 0 | 10 | 10 | 10 |
| Current assets | 0 | 1,505 | 0 | 2,234 |
| Total assets | 0 | 1,515 | 10 | 2,244 |
|
Taxes paid
|
||||
| STI taxes | - | 305 | - | - |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | +175.3% | +77.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | -472.5% | -17090.0% | 75.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | -472.5% | -17090.0% | 75.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -96.8% | -8.4% | 4.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -96.8% | -8.4% | 4.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
SanRetus Medica - Social security debts
The amount of overdue SODRA debt for the company SanRetus Medica as of the last working day is: 161 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-16 | 160.96 |
| 2026-09-01 | 2026-09-02 | 160.96 |
| 2026-08-26 | 2026-08-31 | 80.48 |
| 2026-08-23 | 2026-08-23 | 80.48 |
| 2026-08-19 | 2026-08-19 | 80.48 |
| 2026-08-16 | 2026-08-17 | 80.48 |
| 2026-08-01 | 2026-08-14 | 80.48 |
| 2026-07-01 | 2026-07-31 | 160.96 |
| 2026-06-02 | 2026-06-30 | 80.48 |
| 2026-04-01 | 2026-04-30 | 80.48 |
| 2026-02-03 | 2026-02-28 | 80.48 |
| 2026-01-01 | 2026-01-31 | 217.35 |
| 2025-12-30 | 2025-12-31 | 144.90 |
| 2025-12-02 | 2025-12-29 | 217.35 |
| 2025-11-01 | 2025-12-01 | 144.90 |
| 2025-09-02 | 2025-10-31 | 72.45 |
| 2025-05-04 | 2025-05-31 | 72.45 |
| 2025-02-01 | 2025-04-30 | 72.45 |
| 2024-11-04 | 2024-11-30 | 129.00 |
| 2024-09-03 | 2024-11-03 | 64.50 |
| 2024-08-01 | 2024-08-31 | 64.50 |
| 2024-03-01 | 2024-03-31 | 129.00 |
| 2024-02-01 | 2024-02-29 | 64.50 |
| 2024-01-03 | 2024-01-31 | 58.63 |
| 2023-12-01 | 2023-12-31 | 58.63 |
| 2023-10-03 | 2023-10-31 | 58.63 |
| 2023-08-01 | 2023-09-30 | 58.63 |
| 2023-05-04 | 2023-06-30 | 58.63 |
| 2023-04-03 | 2023-04-30 | 58.63 |
| 2023-02-01 | 2023-03-31 | 58.63 |
SanRetus Medica - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
SanRetus Medica, MB (code 306206106) is a Small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, the company generated €36.1K in revenue, up 77.3% year on year and 388.2% over two years. Net profit turned positive at €1.7K, compared with a loss of €1.7K in 2024 and a loss of €7.2K in 2023, showing a clear improvement in operating performance. The 2025 profit margin was 4.7%. The balance sheet remained very small, with total assets and equity both at €2.2K at year-end 2025, and long-term assets of €10. This indicates a tightly financed structure with equity covering the asset base. Asset turnover reached 16.08x in 2025, reflecting high revenue generation relative to the small asset base. Earlier results show the company moving from a loss-making start in 2023 to break-even improvement in 2024 and profitability in 2025.